Loading...
Cann Group Limited
CNGGF•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.006
$0.00(0.00%)
Cann Group Limited (CNGGF) Stock Overview
Explore Cann Group Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
11.58%
↑ 11.58%
Profit Growth
$-0.12
↓ 51.65%
EPS Growth
$-0.12
↓ 21.15%
Operating Margin
-114.17%
↑ 63.82%
ROE
-159.56%
↓ 51.65%
Dividend Yield
0.00%
Analyst Recommendations data is not available for CNGGFAnalyst Recommendations details for CNGGF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
CEO
Ms. Jennifer Lee Pilcher AGIA, BBS, C.A.
Headquarters
262-276 Lorimer Street, Port Melbourne, VIC
Founded
2021